Surface Oncology (SURF) Financials

$1.07

$0.00 (0.00%)

As on 12-Sep-2023 09:30EDT

Market cap

$66 Mln

Revenue (TTM)

$30 Mln

P/E Ratio

--

P/B Ratio

0.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	30.00	30.00	2.69	126.16	15.36	59.42
Cost of Revenue	--	--	--	--	52.12	52.49
Gross Profit	30.00	30.00	2.69	126.16	15.36	59.42
Operating Expenses	86.15	91.87	78.70	64.58	72.73	68.57
Operating Profit (EBIT)	-89.39	-61.87	-76.01	61.59	-57.37	-9.15
Other Income	1.90	--	0.07	--	--	--
Profit before Tax	-92.51	-63.59	-78.49	59.34	-54.79	-6.60
Provision for Tax	5.17	1.72	0.98	0.58	-1.79	2.55
Profit after Tax (Net Income)	-94.01	-65.30	-79.46	59.34	-53.00	-6.60
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-71.17	--	-78.49	59.34	-54.79	-6.61

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	49.18	93.40	118.90	155.75	56.67	102.86
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	50.25	51.92	43.74	55.75	44.03
Current Liabilities	16.83	16.26	20.02	17.65	19.27	27.18
Total Liabilities	82.83	159.91	190.85	217.14	131.69	174.07

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	5.42	30.77	33.50	36.63	23.77	9.46
Current Assets	60.59	129.14	157.35	180.51	107.93	164.60
Total Assets	82.83	159.91	190.85	217.14	131.69	174.07
Total Debt*	9.49	56.04	57.31	49.27	25.04	--
Net Current Assets	43.76	112.88	137.32	162.86	88.65	137.42

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-59.55	-62.34	30.00	-60.14	-13.22
Cash Flow from Investing Activities	--	--	-99.25	58.31	16.97	-36.58
Cash from Financing Activities	--	31.66	42.50	40.08	7.42	110.38
Net Cash Inflow / Outflow	--	--	-119.10	128.39	-35.76	60.57

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-1.56	-1.08	-1.71	1.37	-1.90	-0.24
Cash EPS ($)	--	-1.06	-1.68	1.41	-1.84	-0.19
Adjusted Book Value ($)	--	1.54	2.56	3.60	2.03	3.72
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.98	-1.34	0.69	-2.16	-0.48
Free Cash Flow per Share ($)	--	-0.99	-1.35	0.69	-2.21	-0.55

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-40.11	-41.69	41.39	-57.44	-15.69
ROE (%)	-136.99	-61.52	-57.86	55.87	-66.45	-15.69
ROA (%)	-63.40	-37.24	-38.95	34.02	-34.67	-5.16
EBIT Margin (%)	-286.42	-206.23	-2,828.92	48.82	-373.48	-15.40
Net Margin (%)	-294.71	-217.68	-2,878.02	47.03	-345.08	-11.10
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	-1.79	10.16	-0.98	7.21	-0.74	3.63
EBIT Growth (%)	-40.84	18.61	-223.43	207.36	-526.88	80.10
Net Profit Growth (%)	-53.69	17.82	-233.92	211.95	-703.46	85.46
EPS Growth (%)	-19.54	0.37	-2.25	1.72	-6.98	0.90
Book Value Growth (%)	-64.79	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-0.76	-2.79	6.74	-0.99	-17.79
Price / Book Value	0.47	0.53	1.87	2.57	0.93	1.14
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.59	0.32	-1.68	4.33	0.50	15.04
Close Price ($)	0.87	0.82	4.78	9.24	1.88	4.24
High Price ($)	2.15	5.16	14.40	11.68	6.17	18.18
Low Price ($)	0.56	0.60	4.64	1.38	1.15	3.45
Market Cap ($ Cr)	65.69	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	0.60	0.48	0.32	0.44	--
Short term debt to equity ratio	0.19	0.06	0.05	0.04	0.05	0.30
Current Ratio	3.60	7.94	7.86	10.23	5.60	6.06
Quick Ratio	3.60	7.95	7.90	10.37	5.62	--
Interest Coverage	-17.43	-36.03	-30.75	27.38	--	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	0.66	28.47	2.04	2.19	0.54
Asset Turnover	0.20	0.17	0.01	0.72	0.10	0.47
Receivable days	--	5.86	226.74	4.21	7.84	1.83
Inventory Days	--	--	--	--	-2.35	--
Payable days	--	--	--	--	23.81	23.06
Cash Conversion Cycle	--	--	--	--	-18.33	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.